Nanopsychiatry-The potential role of nanotechnologies in the future of psychiatry: A systematic review

European Neuropsychopharmacology

Volumn 23, Issue 9, 2013, Pages 1067-1071

  Fond, G ^a,b,c   Macgregor, A ^a,b,c   Miot, S ^a,b,d,e  

^a UNIV MONTPELLIER   (France)

^b INSERM   (France)

^c Montpellier 1 University   (France)

^d Université Pierre et Marie Curie   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

Imaging; Intelligence; Metabolome; Nanocarriers; Nanomedicine

Indexed keywords

CONTRAST MEDIUM; DENDRIMER; LIPOSOME; NANOBUBBLE; NANOMATERIAL; NANOPARTICLE; NANOSHELL; PSYCHOTROPIC AGENT;

ALZHEIMER DISEASE; ARTICLE; BIOAVAILABILITY; BLOOD BRAIN BARRIER; BRAIN TUMOR; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INTERNALIZATION; MENTAL DISEASE; METABOLOME; NANOMEDICINE; NANOPSYCHIATRY; NANOTECHNOLOGY; NERVE CELL NETWORK; NUCLEAR MAGNETIC RESONANCE; PARKINSON DISEASE; PHARMACOLOGICAL SCIENCE; PRIORITY JOURNAL; PSYCHIATRY; QUANTUM MECHANICS; SELF STIMULATION; SENILE PLAQUE; SYNAPSE; SYSTEMATIC REVIEW; TARGET CELL;

IMAGING; INTELLIGENCE; METABOLOME; NANOCARRIERS; NANOMEDICINE;

FORECASTING; HUMANS; MENTAL DISORDERS; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; PSYCHIATRY;

EID: 84884206418     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.10.016     Document Type: Article

References (20)

1. Chertok B., David A.E., Yang V.C. Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials 2010, 31:6317-6324.
2. Duarte I.F. Following dynamic biological processes through NMR-based metabonomics: a new tool in nanomedicine?. J. Control Release 2011, 153:34-39.
3. Food and Drug Administration, 08-21-2012. http://www.fda.org.
4. Fraiman D., Balenzuela P., Foss J., Chialvo D.R. Ising-like dynamics in large-scale functional brain networks. Phys. Rev. E Stat. Nonlinear Soft Matter Phys. 2009, 79:061922.
5. Likharev K., Mayr A., Muckra I., Turel O. CrossNets: high-performance neuromorphic architectures for CMOL circuits. Ann. N. Y. Acad. Sci. 2003, 1006:146-163.
6. McBain S.C., Yiu H.H., Dobson J. Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomed. 2008, 3:169-180.
7. Moghimi S.M. Bionanotechnologies for treatment and diagnosis of Alzheimer's disease. Nanomedicine 2011, 7:515-518.
8. Ohno T., Hasegawa T., Tsuruoka T., Terabe K., Gimzewski J.K., Aono M. Short-term plasticity and long-term potentiation mimicked in single inorganic synapses. Nat. Mater. 2011, 10:591-595.
9. Palanisamy V., Sharma S., Deshpande A., Zhou H., Gimzewski J., Wong D.T. Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS One 2010, 5:e8577.
10. Pan D., Carauthers S.D., Chen J., Winter P.M., SenPan A., Schmieder A.H., Wickline S.A., Lanza G.M. Nanomedicine strategies for molecular targets with MRI and optical imaging. Future Med. Chem. 2010, 2:471-490.
11. Pardridge W.M. Molecular Trojan horses for blood-brain barrier drug delivery. Discovery Med. 2006, 6:139-143.
12. Pautler M., Brenner S. Nanomedicine: promises and challenges for the future of public health. Int. J. Nanomed. 2010, 5:803-809.
13. Roney C., Kulkarni P., Arora V., Antich P., Bonte F., Wu A., Mallikarjuana N.N., Manohar S., Liang H.F., Kulkarni A.R., Sung H.W., Sairam M., Aminabhavi T.M. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. J. Control Release 2005, 108:193-214.
14. Sporns O., Chialvo D.R., Kaiser M., Hilgetag C.C. Organization, development and function of complex brain networks. Trends Cogn. Sci. 2004, 8:418-425.
15. Stolp H.B., Dziegielewska K.M. Review: role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol. Appl. Neurobiol. 2009, 35:132-146.
16. Surendiran A., Sandhiya S., Pradhan S.C., Adithan C. Novel applications of nanotechnology in medicine. Indian J. Med. Res. 2009, 130:689-701.
17. Szebeni J. Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry. Neuropsychopharmacol. Hung. 2011, 13:15-24.
18. Wagner V., Dullaart A., Bock A.K., Zweck A. The emerging nanomedicine landscape. Nat. Biotechnol. 2006, 24:1211-1217.
19. Wang J., Byrne J.D., Napier M.E., DeSimone J.M. More effective nanomedicines through particle design. Small 2011, 7:1919-1931.
20. Wang Z.H., Wang Z.Y., Sun C.S., Wang C.Y., Jiang T.Y., Wang S.L. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials 2010, 31:908-915.